We are live on ! Find out more
BC

Broadwood Capital Portfolio holdings

AUM $1.42B
1-Year Est. Return 34.72%
This Fund
S&P 500
This Quarter Est. Return
-13.34%
1 Year Est. Return
+34.72%
3 Year Est. Return
+45.97%
5 Year Est. Return
+44.27%
10 Year Est. Return
+866.96%
AUM
$1.42B
AUM Growth
-$283M
Cap. Flow
-$30.8M
Cap. Flow %
-2.17%
Top 10 Hldgs %
100%
Holding
12
New
Increased
2
Reduced
1
Closed
6

Top Buys

Rank Stock Value
1
STAA icon
STAAR Surgical
STAA
+$21.1M
2
IMDX
Insight Molecular Diagnostics
IMDX
+$3.03M

Top Sells

Rank Stock Value
1
MNST icon
Monster Beverage
MNST
+$7.19M
2
SER icon
Serina Therapeutics
SER
+$104K

Sector Composition

Rank Sector Weight
1 Consumer Staples 41.41%
2 Healthcare 29.53%
3 Industrials 20.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MNST icon
1
Monster Beverage
MNST
$94.3B
$587M 41.41%
8,107,796
-91,200
-1% -$7.19M
STAA icon
2
STAAR Surgical
STAA
$1.21B
$302M 21.25%
16,123,842
+1,104,351
+7% +$21.1M
AXON
3
Axon Enterprise
AXON
$42.5B
$295M 20.76%
693,504
IWM icon
4
iShares Russell 2000 ETF
IWM
$79.8B
$118M 8.3%
474,920
LCTX icon
5
Lineage Cell Therapeutics
LCTX
$269M
$78.3M 5.52%
49,560,992
IMDX
6
Insight Molecular Diagnostics
IMDX
$150M
$39.1M 2.76%
11,931,839
+521,739
+5% +$3.03M
AAL icon
7
CALL
American Airlines Group
AAL
$10.1B
-820,000
Closed -$12.6M
DAL icon
8
CALL
Delta Air Lines
DAL
$57.5B
-52,500
Closed -$3.64M
GIL icon
9
CALL
Gildan
GIL
$10.3B
-112,750
Closed -$7.04M
LUV icon
10
CALL
Southwest Airlines
LUV
$22B
-183,000
Closed -$7.56M
UAL icon
11
CALL
United Airlines
UAL
$39.4B
-150,000
Closed -$16.8M
SER icon
12
Serina Therapeutics
SER
$30M
-54,484
Closed -$104K

Similar funds

Broadwood Capital's Q1 2026 Portfolio in Review

As of Q1 2026, Broadwood Capital held 12 positions worth $1.42B, down 17% from $1.7B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Broadwood Capital's Q1 2026 filing shows 2 increased, 1 reduced and 6 closed positions. The largest sale was Monster Beverage, an estimated $7.19M.

By sector, the portfolio is most concentrated in Consumer Staples at 41% of assets, up from 37% a quarter earlier, followed by Healthcare and Industrials.

  • Broadwood Capital added most to STAAR Surgical in Q1 2026, an estimated $21.1M increase.
  • Broadwood Capital's biggest Q1 2026 reduction was Monster Beverage, cutting an estimated $7.19M.
  • Broadwood Capital fully exited Serina Therapeutics in Q1 2026, selling an estimated $104K.
  • Broadwood Capital's ten largest holdings make up 100% of its $1.42B portfolio in Q1 2026.
  • Broadwood Capital opened 0 new positions and closed 6 in Q1 2026.
  • Broadwood Capital's portfolio value fell 17% quarter-over-quarter to $1.42B.

Based on Broadwood Capital's 13F filing for Q1 2026, filed 15 May 2026.